Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide.

References 1. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015–23. 2. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society. Joint British recommendations on prevention of coronary disease in clinical practice. Heart 1998;80(Suppl2):S1–29. 3. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998;140:199–270. 4. National Heart Foundation. Clinical guidelines for the assessment and management of dyslipidaemia. N Z Med J 1996;109:224–32. 5. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991;121:293–8. 6. Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet 1996;348:387–8. 7. Jones AF, Walker J, Jewkes C, Game FL, Bartlett WA, Marshall T, Bayly GR. Comparative accuracy of cardiovascular risk prediction methods in general practice patients. Heart 2001;85:37–43. 8. Bayly GR, Bartlett WA, Davies PH, Husband D, Haddon A, Game FL, Jones AF. Laboratory-based calculation of coronary heart disease risk in a hospital diabetic clinic. Diabet Med 1999;16:697–701. 9. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. CRC Crit Rev Clin Lab Sci 1989;27:409–37. 10. Durrington PN, Prais H, Bhatnagar D, France M, Crowley V, Khan J, Morgan J. Indication for cholesterol-lowering medication: comparison of risk-assessment method. Lancet 1999;353:278–81. 11. Isles CG, Ritchie LD, Murchie P, Norrie J. Risk assessment in primary prevention of coronary heart disease: randomized comparison of three scoring methods. BMJ 2000;320:690–1. 12. Jones AF. Statins and hypercholestrolaemia: UK Standing Medical Advisory Committee Guidelines. Lancet 1997;350:1174–5. 13. Jones AF, Game FL. Cardiovascular risk assessment. Mod Hypertens Manage 1999;1:10–3. 14. Hingorani AD, Vallance P. A simple computer program for guiding management of cardiovascular risk factors and prescribing. BMJ 1999;318:101–5. 15. The National Service framework of coronary heart disease. Modern standards and service models. London: Department of Health, 2000.